Literature DB >> 9830740

[Enteral nutrition in severe ulcerative colitis. Digestive tolerance and nutritional efficiency].

J Klaassen1, R Zapata, J G Mella, G Aguayo, D Alvarado, O Espinosa, A Maíz, A Zúñiga, C Quintana.   

Abstract

BACKGROUNDS AND AIMS: Total parenteral nutrition (TPN) has been traditionally used as an adjunctive therapy in severe ulcerative colitis patients. We performed a prospective study to ascertain the safety, nutritional efficiency, tolerance and costs of total enteral nutrition in this situation.
METHODS: After 48 hours of intensive medical treatment, severe ulcerative colitis patients initiated enteral feeding with a polymeric formula. The formula concentration and volume were increased daily.
RESULTS: 17 patients (7 women, 10 men; age 36.8 +/- 12.8 years) with a mean clinical activity score of 15.6 +/- 1.5 were included. In 14 patients (82.4%) enteral nutrition was well tolerated, attaining in 11 of them more than 80% of the caloric requirements by day 4. In 3 cases we observed vomiting and bloating. Prealbumin levels improved significantly from 11.1 +/- 3.4 mg/dl to 22.7 +/- 6.8 mg/dl (p = 0.002) at the end of enteral nutrition (11.8 +/- 4.7 days). Albumin and other nutritional parameters did not change.
CONCLUSIONS: Total enteral nutrition could be considered a safe and well tolerated nutritional support in these patients. Although albumin and other nutritional parameters did not change during the study period, the increase in prealbumin levels suggests a favourable anabolic effect of total enteral nutrition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830740

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  6 in total

1.  The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.

Authors:  Brian P Ciampa; Emmanuel Reyes Ramos; Marie Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-02

2.  Monotonous diets protect against acute colitis in mice: epidemiologic and therapeutic implications.

Authors:  Dorottya Nagy-Szakal; Sabina A V Mir; Matthew C Ross; Nina Tatevian; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-05       Impact factor: 2.839

Review 3.  The role of enteral nutrition in patients with inflammatory bowel disease: current aspects.

Authors:  John K Triantafillidis; Costas Vagianos; Apostolos E Papalois
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

4.  Diet and inflammatory bowel disease: The Asian Working Group guidelines.

Authors:  Ajit Sood; Vineet Ahuja; Saurabh Kedia; Vandana Midha; Ramit Mahajan; Varun Mehta; Ritu Sudhakar; Arshdeep Singh; Ajay Kumar; Amarender Singh Puri; Bailuru Vishwanath Tantry; Babu Ram Thapa; Bhabhadev Goswami; Banchha Nidhi Behera; Byong Duk Ye; Deepak Bansal; Devendra Desai; Ganesh Pai; Ghulam Nabi Yattoo; Govind Makharia; Hasitha Srimal Wijewantha; Jayanthi Venkataraman; K T Shenoy; Manisha Dwivedi; Manoj Kumar Sahu; Meenakshi Bajaj; Murdani Abdullah; Namrata Singh; Neelanjana Singh; Philip Abraham; Rajiv Khosla; Rakesh Tandon; S P Misra; Sandeep Nijhawan; Saroj Kant Sinha; Sawan Bopana; Sheela Krishnaswamy; Shilpa Joshi; Shivram Prasad Singh; Shobna Bhatia; Sudhir Gupta; Sumit Bhatia; Uday Chand Ghoshal
Journal:  Indian J Gastroenterol       Date:  2019-07-27

5.  Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?

Authors:  Yong Eun Park; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim; Jung Nam Kim; Na Rae Lee; Jae Hee Cheon
Journal:  Intest Res       Date:  2019-07-19

6.  The Effect of Enteral Nutrition Support Rich in TGF-β in the Treatment of Inflammatory Bowel Disease in Childhood.

Authors:  Mehmet Agin; Aylin Yucel; Meltem Gumus; Hasan Ali Yuksekkaya; Gokhan Tumgor
Journal:  Medicina (Kaunas)       Date:  2019-09-22       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.